Wangping Neurosurgical
Welcome,         Profile    Billing    Logout  
 8 Trials 
10 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wang, Ping H
NCT03708042: A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer

Not yet recruiting
3
220
NA
Definitive Radiochemotherapy, Neoadjuvant Radiochemotherapy
Tianjin Medical University Cancer Institute and Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Sun Yat-sen University, Peking University Cancer Hospital & Institute
Stage II Esophageal Cancer, Stage III Esophageal Cancer
12/21
12/23
ACROSS1, NCT04500704: Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLC

Not yet recruiting
3
166
RoW
Almonertinib, Ameile, Almonertinib plus carboplatin and pemetrexed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Jiangsu Hansoh Pharmaceutical Co., Ltd.
Non Small Cell Lung Cancer
12/21
10/23
ACROSS2, NCT04500717: Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene Mutation

Not yet recruiting
3
460
RoW
Almonertinib, Aleime, Almonertinib plus carboplatin and pemetrexed
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Jiangsu Hansoh Pharmaceutical Co., Ltd.
Non Small Cell Lung Cancer
10/22
10/23
NANORAY-312, NCT04892173 / 2021-002163-22: JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Recruiting
3
500
Europe, Japan, US, RoW
JNJ-90301900 (NBTXR3), Functionalized hafnium oxide nanoparticles, NBTXR3, Cetuximab, Erbitux, Radiation Therapy
Johnson & Johnson Enterprise Innovation Inc., Nanobiotix SA
Locally Advanced Head and Neck Squamous Cell Carcinoma, Aged
06/26
06/27
TQB2450-III-13, NCT06475599: Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer

Not yet recruiting
3
420
RoW
Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Endometrial Cancer
12/27
06/29
TQB2102-II-05, NCT06798207: A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced

Not yet recruiting
2
90
RoW
TQB2102 for injection
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Gynecological Tumors
05/26
11/26
NCT04968730: Establishment and Application of Early Postoperative Activity Plan for Patients After Hemi-laminectomy for Lumbar Spinal Tumor Resection

Recruiting
N/A
100
RoW
Postoperative rehabilitation nursing
Second Affiliated Hospital, School of Medicine, Zhejiang University
Tumor of Spinal Cord
12/22
12/22
NCT06686134: Comprehensive Clinical Evaluation Study of GLP-1RA

Recruiting
N/A
492
RoW
LI YAN
T2DM
12/25
07/26
NCT04776408: Potential for Inhaled Nitric Oxide and Ventilation-Perfusion Mismatch by Electrical Impedance Tomography in the ARDS Patients With Lung Recruitment

Enrolling by invitation
N/A
100
RoW
Lung recruitment combined inhaled Nitric oxide, Lung recruitment
Far Eastern Memorial Hospital
Nitric Oxide, Acute Respiratory Distress Syndrome
12/24
12/24
NCT05938881: Long-term Success Rate of Transvaginal Mesh for the Treatment of Pelvic Organ Prolapse: The Extended RCT Study

Recruiting
N/A
336
RoW
self-cut mesh procedure, mesh-kit procedure
Peking Union Medical College Hospital
Pelvic Organ Prolapse
01/33
03/33

Download Options